Vertex Pharmaceuticals

$219.39
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.71 (-0.77%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell VRTX and other stocks, options, and ETFs commission-free!

About VRTX

Vertex Pharmaceuticals Incorporated Common Stock, also called Vertex Pharmaceuticals, is a global biotechnology company. It engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases.

CEO

Reshma Kewalramani

Employees

3,400

Headquarters

Boston, Massachusetts

Founded

1989

Market Cap

55.46B

Price-Earnings Ratio

21.31

Dividend Yield

—

Average Volume

1.75M

High Today

$222.78

Low Today

$219.24

Open Price

$222.34

Volume

1.91M

52 Week High

$306.08

52 Week Low

$202.57

Analyst Ratings

86%

of 28 ratings

Buy

86%

Hold

14%

Sell

VRTX Earnings

$0.00

$0.88

$1.76

$2.64

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected Apr 29, After Hours